Edition:
United States

Protalex Inc (PRTX.PK)

PRTX.PK on OTC Markets Group

1.44USD
--
Change (% chg)

-- (--)
Prev Close
$1.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,715
52-wk High
$4.50
52-wk Low
$0.55

PRTX.PK

Chart for PRTX.PK

About

Protalex, Inc. is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company's lead product candidate, PRTX-100, is a formulation of the Staphylococc... (more)
No analyst recommendations are available for PRTX.PK.

Overall

Beta: 1.09
Market Cap(Mil.): $41.43
Shares Outstanding(Mil.): 28.77
Dividend: --
Yield (%): --

Financials

  PRTX.PK Industry Sector
P/E (TTM): -- 29.30 30.07
EPS (TTM): -0.20 -- --
ROI: -6,241.86 13.52 13.05
ROE: -- 14.43 14.20

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.